A AL-Sabbagh

1.5k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

A AL-Sabbagh is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, A AL-Sabbagh has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Pathology and Forensic Medicine and 5 papers in Molecular Biology. Recurrent topics in A AL-Sabbagh's work include Multiple Sclerosis Research Studies (9 papers), T-cell and Retrovirus Studies (3 papers) and Immunotherapy and Immune Responses (3 papers). A AL-Sabbagh is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), T-cell and Retrovirus Studies (3 papers) and Immunotherapy and Immune Responses (3 papers). A AL-Sabbagh collaborates with scholars based in United States, Canada and United Kingdom. A AL-Sabbagh's co-authors include Howard L. Weiner, Ariel Miller, R. B. Nussenblatt, D A Hafler, Trentham De, Samia J. Khoury, Aharon Friedman, Mohamed H. Sayegh, Leonilda Maria Barbosa dos Santos and Liliane Martins dos Santos and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Annual Review of Immunology.

In The Last Decade

A AL-Sabbagh

22 papers receiving 1.2k citations

Hit Papers

Oral Tolerance: Immunologic Mechanisms and Treatment of A... 1994 2026 2004 2015 1994 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens
    1994 746 citations Howard L. Weiner, Aharon Friedman et al. Annual Review of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A AL-Sabbagh United States 9 745 219 174 168 156 22 1.3k
Kim Waggie United States 10 865 1.2× 102 0.5× 167 1.0× 229 1.4× 180 1.2× 12 1.5k
Elizabeth G. Lingenheld United States 19 1.2k 1.6× 183 0.8× 83 0.5× 238 1.4× 92 0.6× 25 1.6k
H. A. Drexhage Netherlands 23 781 1.0× 84 0.4× 278 1.6× 151 0.9× 76 0.5× 57 1.5k
Tchavdar L. Vassilev Bulgaria 23 840 1.1× 108 0.5× 101 0.6× 403 2.4× 616 3.9× 57 1.5k
Giuseppe De Panfilis Italy 19 519 0.7× 116 0.5× 44 0.3× 222 1.3× 64 0.4× 73 1.1k
Shinji Kagami Japan 18 1.1k 1.4× 151 0.7× 56 0.3× 242 1.4× 43 0.3× 45 1.7k
Trentham De United States 7 553 0.7× 48 0.2× 146 0.8× 140 0.8× 130 0.8× 11 1.0k
Carole L. Galligan Canada 20 644 0.9× 60 0.3× 82 0.5× 274 1.6× 71 0.5× 31 1.3k
S Tagawa Japan 16 901 1.2× 417 1.9× 127 0.7× 602 3.6× 113 0.7× 47 1.9k
Christine Wallon France 23 777 1.0× 69 0.3× 61 0.4× 195 1.2× 156 1.0× 38 1.4k

Countries citing papers authored by A AL-Sabbagh

Since Specialization
Citations

This map shows the geographic impact of A AL-Sabbagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A AL-Sabbagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A AL-Sabbagh more than expected).

Fields of papers citing papers by A AL-Sabbagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A AL-Sabbagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A AL-Sabbagh. The network helps show where A AL-Sabbagh may publish in the future.

Co-authorship network of co-authors of A AL-Sabbagh

This figure shows the co-authorship network connecting the top 25 collaborators of A AL-Sabbagh. A scholar is included among the top collaborators of A AL-Sabbagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A AL-Sabbagh. A AL-Sabbagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
AL-Sabbagh, A, et al.. (2024). The Impacts of Exercises on Health-related Quality of Life in Cancer Patients: A Narrative Review. 12(Autumn Supplementary). 0–0. 2 indexed citations
2.
3.
AL-Sabbagh, A, et al.. (2015). Patient Understanding and Attitudes About Biosimilars: An International Cross-Sectional Survey. Value in Health. 18(7). A680–A680. 1 indexed citations
4.
Udata, Chandrasekhar, Dong Yin, Steven Y. Hua, et al.. (2015). SAT0142 Immunogenicity Assessment of PF-06438179, A Potential Biosimilar to Infliximab, In Healthy Volunteers. Annals of the Rheumatic Diseases. 74. 702–702. 4 indexed citations
5.
6.
AL-Sabbagh, A, et al.. (2007). Successful transcatheter embolisation of iliac artery mycotic aneurysm in a neonate. Archives of Disease in Childhood Fetal & Neonatal. 92(2). F135–F136. 2 indexed citations
7.
Neema, Mohit, James Stankiewicz, Ashish Arora, et al.. (2007). T1‐ and T2‐Based MRI Measures of Diffuse Gray Matter and White Matter Damage in Patients with Multiple Sclerosis. Journal of Neuroimaging. 17(s1). 16S–21S. 96 indexed citations
8.
Simsarian, James, A AL-Sabbagh, Robert M. Bennett, Bettina Stubinski, & Gabriel Pardo. (2007). PND2 SAFETY AND IMMUNOGENICITY OF REBIF® NEW FORMULATION (RNF) A NEW SUBCUTANEOUS FORMULATION OF INTERFERON BETA-1A 44 MCG THREE TIMES WEEKLY: 1-YEAR RESULTS OF A PHASE IIIB STUDY IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS. Value in Health. 10(3). A87–A87. 1 indexed citations
9.
AL-Sabbagh, A. (2007). Neutralizing antibodies in MS therapy: reviewing the Rebif experience. Multiple Sclerosis Journal. 13(1_suppl). 8–13. 3 indexed citations
10.
Cramer, Joyce A., et al.. (2006). Patient satisfaction with an injection device for multiple sclerosis treatment. Acta Neurologica Scandinavica. 113(3). 156–162. 55 indexed citations
11.
Yasuda, Clarissa Lin, et al.. (1999). Interferon β Modulates Experimental Autoimmune Encephalomyelitis by Altering the Pattern of Cytokine Secretion. Immunological Investigations. 28(2-3). 115–126. 30 indexed citations
12.
Mastronardi, Fabrizio G., et al.. (1996). Myelin basic protein in experimental allergic encephalomyelitis is not affected at the posttranslational level: Implications for demyelinating disease. Journal of Neuroscience Research. 44(4). 344–349. 11 indexed citations
13.
14.
Mastronardi, Fabrizio G., et al.. (1996). Myelin basic protein in experimental allergic encephalomyelitis is not affected at the posttranslational level: Implications for demyelinating disease. Journal of Neuroscience Research. 44(4). 344–349. 1 indexed citations
15.
Markovic‐Plese, Silva, Hikoaki Fukaura, A AL-Sabbagh, et al.. (1995). T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. The Journal of Immunology. 155(2). 982–992. 107 indexed citations
16.
Miller, Ariel, Samia J. Khoury, A AL-Sabbagh, et al.. (1995). Treatment of autoimmune diseases by oral tolerance to autoantigens.. PubMed. 371B. 1217–23. 5 indexed citations
17.
Kuchroo, Vijay K., Mary Collins, A AL-Sabbagh, et al.. (1994). T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice.. The Journal of Experimental Medicine. 179(5). 1659–1664. 30 indexed citations
18.
Weiner, Howard L., Aharon Friedman, Ariel Miller, et al.. (1994). Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens. Annual Review of Immunology. 12(1). 809–837. 746 indexed citations breakdown →
19.
Miller, Ariel, A AL-Sabbagh, Liliane Martins dos Santos, Mrinmoy Das, & Howard L. Weiner. (1993). Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.. The Journal of Immunology. 151(12). 7307–7315. 136 indexed citations
20.
Krenger, Werner, Dag H. Yasui, A AL-Sabbagh, Subramaniam Sriram, & David Johnson. (1991). Mast cell activation in murine EAE. Journal of Neuroimmunology. 35. 45–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim Waggie Breakdown of academic impact, for papers by Elizabeth G. Lingenheld Breakdown of academic impact, for papers by H. A. Drexhage Breakdown of academic impact, for papers by Tchavdar L. Vassilev Breakdown of academic impact, for papers by Giuseppe De Panfilis Breakdown of academic impact, for papers by Shinji Kagami Breakdown of academic impact, for papers by Trentham De Breakdown of academic impact, for papers by Carole L. Galligan Breakdown of academic impact, for papers by S Tagawa Breakdown of academic impact, for papers by Christine Wallon
Rankless by CCL
2026